↓ Skip to main content

Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell…

Overview of attention for article published in Investigational New Drugs, July 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

patent
12 patents

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
23 Mendeley
connotea
1 Connotea
Title
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines
Published in
Investigational New Drugs, July 2006
DOI 10.1007/s10637-006-9000-0
Pubmed ID
Authors

Yasuhiko Kano, Miyuki Akutsu, Saburo Tsunoda, Tohru Izumi, Hiroyuki Kobayashi, Hiroyuki Mano, Yusuke Furukawa

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovakia 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 35%
Researcher 6 26%
Student > Doctoral Student 2 9%
Student > Bachelor 1 4%
Professor 1 4%
Other 4 17%
Unknown 1 4%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 35%
Medicine and Dentistry 6 26%
Biochemistry, Genetics and Molecular Biology 2 9%
Chemistry 2 9%
Immunology and Microbiology 1 4%
Other 1 4%
Unknown 3 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2020.
All research outputs
#3,315,928
of 23,033,713 outputs
Outputs from Investigational New Drugs
#90
of 1,174 outputs
Outputs of similar age
#7,139
of 66,045 outputs
Outputs of similar age from Investigational New Drugs
#1
of 4 outputs
Altmetric has tracked 23,033,713 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,174 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,045 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them